Comparison of K-ras point mutation distributions in intraductal papillary-mucinous tumors and ductal adenocarcinoma of the pancreas

Minoru Kitago, Masakazu Ueda, Koichi Aiura, Keiichi Suzuki, Sojun Hoshimoto, Shin Takahashi, Makio Mukai, Masaki Kitajima

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Intraductal papillary-mucinous tumors (IPMT) consist of cells with varying histologic degrees of severity and exhibit multiple tumor loci; however, whether or not these lesions exhibit the same genetic changes has not been clarified. To investigate this point, we analyzed K-ras mutations in multiple IPMT lesions from each patient enrolled in our study and compared our findings to those for patients with ductal adenocarcinoma of the pancreas (DC). Twenty IPMT specimens and 7 DC specimens were resected, microdissected and analyzed for the presence of K-ras mutations. The mutated genes were then sequenced using a genetic analyzer. K-ras mutations were observed in 80% of IPMT and 100% of DC patients. More than 2 types of K-ras mutation were observed in the main tumors of 43.8% of IPMT and 0% of DC patients. K-ras mutations in peritumoral and separated lesions were observed in 66.7% and 62.5% of IPMT patients, respectively. At least one identical mutation between the main tumor and the peritumoral or separated lesions was recognized in all of the IPMT patients with those lesions. Different mutations from those in the main tumor were observed in 40% of IPMT patients with separated lesions. The survival curve of IPMT-carcinoma patients with more than 2 types of K-ras mutation in the main tumor was better than that with one type of K-ras mutation. IPMT patients exhibit a remarkably genetic heterogeneity in main tumor and have good prognosis.

Original languageEnglish
Pages (from-to)177-182
Number of pages6
JournalInternational Journal of Cancer
Volume110
Issue number2
DOIs
Publication statusPublished - 2004 Jun 10

Fingerprint

Point Mutation
Pancreas
Adenocarcinoma
Neoplasms
Mutation
Mucinous Adenocarcinoma
Genetic Heterogeneity

Keywords

  • Heterogeneity
  • Intraductal papillary-mucinous tumors
  • Microdissection
  • Non-RI SSCP
  • Postoperative survival rate

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Comparison of K-ras point mutation distributions in intraductal papillary-mucinous tumors and ductal adenocarcinoma of the pancreas. / Kitago, Minoru; Ueda, Masakazu; Aiura, Koichi; Suzuki, Keiichi; Hoshimoto, Sojun; Takahashi, Shin; Mukai, Makio; Kitajima, Masaki.

In: International Journal of Cancer, Vol. 110, No. 2, 10.06.2004, p. 177-182.

Research output: Contribution to journalArticle

Kitago, Minoru ; Ueda, Masakazu ; Aiura, Koichi ; Suzuki, Keiichi ; Hoshimoto, Sojun ; Takahashi, Shin ; Mukai, Makio ; Kitajima, Masaki. / Comparison of K-ras point mutation distributions in intraductal papillary-mucinous tumors and ductal adenocarcinoma of the pancreas. In: International Journal of Cancer. 2004 ; Vol. 110, No. 2. pp. 177-182.
@article{1aa893dee9cb4ee894fad4e3bb24e20b,
title = "Comparison of K-ras point mutation distributions in intraductal papillary-mucinous tumors and ductal adenocarcinoma of the pancreas",
abstract = "Intraductal papillary-mucinous tumors (IPMT) consist of cells with varying histologic degrees of severity and exhibit multiple tumor loci; however, whether or not these lesions exhibit the same genetic changes has not been clarified. To investigate this point, we analyzed K-ras mutations in multiple IPMT lesions from each patient enrolled in our study and compared our findings to those for patients with ductal adenocarcinoma of the pancreas (DC). Twenty IPMT specimens and 7 DC specimens were resected, microdissected and analyzed for the presence of K-ras mutations. The mutated genes were then sequenced using a genetic analyzer. K-ras mutations were observed in 80{\%} of IPMT and 100{\%} of DC patients. More than 2 types of K-ras mutation were observed in the main tumors of 43.8{\%} of IPMT and 0{\%} of DC patients. K-ras mutations in peritumoral and separated lesions were observed in 66.7{\%} and 62.5{\%} of IPMT patients, respectively. At least one identical mutation between the main tumor and the peritumoral or separated lesions was recognized in all of the IPMT patients with those lesions. Different mutations from those in the main tumor were observed in 40{\%} of IPMT patients with separated lesions. The survival curve of IPMT-carcinoma patients with more than 2 types of K-ras mutation in the main tumor was better than that with one type of K-ras mutation. IPMT patients exhibit a remarkably genetic heterogeneity in main tumor and have good prognosis.",
keywords = "Heterogeneity, Intraductal papillary-mucinous tumors, Microdissection, Non-RI SSCP, Postoperative survival rate",
author = "Minoru Kitago and Masakazu Ueda and Koichi Aiura and Keiichi Suzuki and Sojun Hoshimoto and Shin Takahashi and Makio Mukai and Masaki Kitajima",
year = "2004",
month = "6",
day = "10",
doi = "10.1002/ijc.20084",
language = "English",
volume = "110",
pages = "177--182",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Comparison of K-ras point mutation distributions in intraductal papillary-mucinous tumors and ductal adenocarcinoma of the pancreas

AU - Kitago, Minoru

AU - Ueda, Masakazu

AU - Aiura, Koichi

AU - Suzuki, Keiichi

AU - Hoshimoto, Sojun

AU - Takahashi, Shin

AU - Mukai, Makio

AU - Kitajima, Masaki

PY - 2004/6/10

Y1 - 2004/6/10

N2 - Intraductal papillary-mucinous tumors (IPMT) consist of cells with varying histologic degrees of severity and exhibit multiple tumor loci; however, whether or not these lesions exhibit the same genetic changes has not been clarified. To investigate this point, we analyzed K-ras mutations in multiple IPMT lesions from each patient enrolled in our study and compared our findings to those for patients with ductal adenocarcinoma of the pancreas (DC). Twenty IPMT specimens and 7 DC specimens were resected, microdissected and analyzed for the presence of K-ras mutations. The mutated genes were then sequenced using a genetic analyzer. K-ras mutations were observed in 80% of IPMT and 100% of DC patients. More than 2 types of K-ras mutation were observed in the main tumors of 43.8% of IPMT and 0% of DC patients. K-ras mutations in peritumoral and separated lesions were observed in 66.7% and 62.5% of IPMT patients, respectively. At least one identical mutation between the main tumor and the peritumoral or separated lesions was recognized in all of the IPMT patients with those lesions. Different mutations from those in the main tumor were observed in 40% of IPMT patients with separated lesions. The survival curve of IPMT-carcinoma patients with more than 2 types of K-ras mutation in the main tumor was better than that with one type of K-ras mutation. IPMT patients exhibit a remarkably genetic heterogeneity in main tumor and have good prognosis.

AB - Intraductal papillary-mucinous tumors (IPMT) consist of cells with varying histologic degrees of severity and exhibit multiple tumor loci; however, whether or not these lesions exhibit the same genetic changes has not been clarified. To investigate this point, we analyzed K-ras mutations in multiple IPMT lesions from each patient enrolled in our study and compared our findings to those for patients with ductal adenocarcinoma of the pancreas (DC). Twenty IPMT specimens and 7 DC specimens were resected, microdissected and analyzed for the presence of K-ras mutations. The mutated genes were then sequenced using a genetic analyzer. K-ras mutations were observed in 80% of IPMT and 100% of DC patients. More than 2 types of K-ras mutation were observed in the main tumors of 43.8% of IPMT and 0% of DC patients. K-ras mutations in peritumoral and separated lesions were observed in 66.7% and 62.5% of IPMT patients, respectively. At least one identical mutation between the main tumor and the peritumoral or separated lesions was recognized in all of the IPMT patients with those lesions. Different mutations from those in the main tumor were observed in 40% of IPMT patients with separated lesions. The survival curve of IPMT-carcinoma patients with more than 2 types of K-ras mutation in the main tumor was better than that with one type of K-ras mutation. IPMT patients exhibit a remarkably genetic heterogeneity in main tumor and have good prognosis.

KW - Heterogeneity

KW - Intraductal papillary-mucinous tumors

KW - Microdissection

KW - Non-RI SSCP

KW - Postoperative survival rate

UR - http://www.scopus.com/inward/record.url?scp=2342544035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342544035&partnerID=8YFLogxK

U2 - 10.1002/ijc.20084

DO - 10.1002/ijc.20084

M3 - Article

C2 - 15069678

AN - SCOPUS:2342544035

VL - 110

SP - 177

EP - 182

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 2

ER -